Back to the future: Using inhalers correctly

Respiratory Care

Volumn 53, Issue 3, 2008, Pages 314-315

  Roth, Bernard J ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; LONG ACTING DRUG; PIRBUTEROL; STEROID;

ASTHMA; BRONCHODILATATION; CAPSULE ENDOSCOPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CAPSULE; DRY POWDER; EDITORIAL; HUMAN; INHALER; MEDICAL NEBULIZER; METERED DOSE INHALER; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; POWDER INHALER; PRESCRIPTION; RESPIRATORY CARE; RESPIRATORY THERAPIST; SOFT MIST INHALER; TECHNIQUE; TREATMENT DURATION; EQUIPMENT; NOTE;

EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HUMANS; METERED DOSE INHALERS; PATIENT COMPLIANCE;

EID: 44449153221     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD. Version 1.2. New York: American Thoracic Society;2004. Updated October 8, 2007.
2. National Asthma Education and Prevention Program Expert Panel Report 3: guidelines for the diagnosis and management of asthma. NIH Publication Number 08-5846. October 2007.
3. Crompton GK. How to achieve good compliance with inhaled asthma therapy. Respir Med 2004;98(Suppl B):S35-S40.
4. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19(2):246-251.
5. Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis 1987;70(2):93-98.
6. Konig P. Spacer devices used with metered-dose inhalers: breakthrough or gimmick? Chest 1985;88(2):276-284.
7. Newman SP. Inhaler treatment options in COPD. Eur Respir Rev 2005;14:102-108.
8. Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler and dry powder inhaler. Respir Care 2005;50(10):1313-1321.
9. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 2005;127(1):335-371.
10. Crompton GK, Barnes PJ. Aerosol delivery devices. Chest 2006;129(5):1388-1389.
11. Khassawneh BY, Al-Ali MK, Alzoubi KH, Baterseh MZ, Al-safi SA, Sharara AM, Alnasar HM. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry-powder inhaler. Respir Care 2008;53(3):324-328.
12. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003;16(3):249-254.
13. Wieshammer S, Dreyhaupt J. Dry-powder inhalers in asthma and COPD: which factors determine the frequency of handling errors? A study of Aerolizer, Discus, HandiHaler, and Turbuhaler (abstract). Chest 2007;132:479S.
14. Dahl R, Backer V, Ollgaard B, Gerken F, Kesten S. Assessment of patient performance of the HandiHaler compared with the metered-dose inhaler four weeks after instruction. Respir Med 2003;97(100):1126-1133.
15. Everard ML. Regimen and device compliance: key factors in determining therapeutic outcomes. J Aerosol Med 2006;19(1):67-73.
16. Allen SC, Ragab S. Ability to learn inhaler techmnique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002;78(915):37-39.
17. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med 2006;100(9):1479-1494.